<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Small Cap Value Fund A Class — News on 6ix</title>
    <link>https://6ix.com/company/small-cap-value-fund-a-class</link>
    <description>Latest news and press releases for Small Cap Value Fund A Class on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/small-cap-value-fund-a-class" rel="self" type="application/rss+xml" />
    <item>
      <title>CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies</title>
      <link>https://6ix.com/company/small-cap-value-fund-a-class/news/cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity-in-dementia-with-lewy-bodies-1</link>
      <guid isPermaLink="true">https://6ix.com/company/small-cap-value-fund-a-class/news/cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity-in-dementia-with-lewy-bodies-1</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the basal</description>
    </item>
  </channel>
</rss>